2026-04-18T07:49:43Zhttps://recercat.cat/oai/requestoai:recercat.cat:20.500.12327/20342025-10-22T11:22:28Zcom_2072_4428com_2072_4427col_2072_487898
Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe
Stelzle, Dominik
Abraham, Annette
Kaminski, Miriam
Schmidt, Veronika
De Meijere, Robert
Bustos, Javier A
Garcia, Hector Hugo
Sahu, Priyadarshi Soumyaranjan
Bobić, Branko
Cretu, Carmen
Chiodini, Peter
Dermauw, Veronique
Devleesschauwer, Brecht
Dorny, Pierre
Fonseca, Ana
Gabriël, Sarah
Gómez Morales, Maria Ángeles
Laranjo-González, Minerva
Hoerauf, Achim
Hunter, Ewan
Jambou, Ronan
Jurhar-Pavlova, Maja
Reiter-Owona, Ingrid
Sotiraki, Smaragda
Trevisan, Chiara
Vilhena, Manuela
Walker, Naomi F
Zammarchi, Lorenzo
Winkler, Andrea Sylvia
Producció Animal
Sanitat Animal
619
Objectives: Neurocysticercosis (NCC) is a parasitic disease caused by the larval stage of the tapeworm Taenia
solium. NCC mainly occurs in Africa, Latin America and South-East Asia and can cause a variety of clinical
signs/symptoms. Although it is a rare disease in Europe, it should nonetheless be considered as a differential
diagnosis. The aim of this study was to describe clinical characteristics and management of patients with NCC
diagnosed and treated in Europe.
Methods: We conducted a systematic search of published and unpublished data on patients diagnosed with NCC
in Europe (2000–2019) and extracted demographic, clinical and radiological information on each case, if available.
Results: Out of 293 identified NCC cases, 59% of patients presented initially with epileptic seizures (21% focal onset);
52% presented with headache and 54% had other neurological signs/symptoms. The majority of patients had a travel
or migration history (76%), mostly from/to Latin America (38%), Africa (32%) or Asia (30%). Treatment varied largely
depending on cyst location and number. The outcome was favorable in 90% of the cases.
Conclusions: Management of NCC in Europe varied considerably but often had a good outcome. Travel and
migration to and from areas endemic for T. solium will likely result in continued low prevalence of NCC in Europe.
Therefore, training and guidance of clinicians is recommended for optimal patient management.
info:eu-repo/semantics/acceptedVersion
2022-10-12
info:eu-repo/semantics/article
Stelzle, Dominik, Annette Abraham, Miriam Kaminski, Veronika Schmidt, Robert De Meijere, Javier A Bustos, and Hector Hugo Garcia et al. 2023. "Clinical Characteristics And Management Of Neurocysticercosis Patients: A Retrospective Assessment Of Case Reports From Europe". Journal Of Travel Medicine 30 (1). doi:10.1093/jtm/taac102.
1195-1982
http://hdl.handle.net/20.500.12327/2034
https://doi.org/10.1093/jtm/taac102
eng
Journal of Travel Medicine
EC/COST/TD1302/EU/European Network on Taeniosis-Cysticercosis/CYSTINET
Copyright © 2022 Oxford University Press
info:eu-repo/semantics/openAccess
28
Oxford University Press